SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 59 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q1 2022$201,000
-41.6%
48,250
-27.3%
0.00%
-55.6%
Q4 2021$344,000
-47.3%
66,327
-33.4%
0.01%
-25.0%
Q3 2021$653,000
+56.2%
99,650
+58.3%
0.01%
+50.0%
Q2 2021$418,00062,9500.01%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q3 2021
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 3,530,657$23,126,0001.85%
TFG Asset Management GP Ltd 2,500,000$16,375,0001.00%
Nantahala Capital Management 2,936,791$19,236,0000.61%
MYDA Advisors LLC 171,953$1,126,0000.32%
SABBY MANAGEMENT, LLC 300,000$1,965,0000.27%
Regency Capital Management Inc.\DE 57,000$373,0000.26%
Ikarian Capital, LLC 544,819$3,568,0000.25%
Eversept Partners, LP 398,074$2,607,3850.18%
Henry James International Management Inc. 54,047$354,0000.11%
Alphabet Inc. 698,262$4,574,0000.11%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders